Previous studies showed that membranous expression of MIC2 glycoprotein (CD99) was detected in 97% of patients, and the most sensitive and specific detection method for the diagnosis of ES/pPNET was a combination of CD99 and FLI-1 immunohistochemistry [21, 22]. The gene discussed is CD99; the disease is Ewing sarcoma.